Skip to main content

Table 1 The clinic- pathological features of patients with pituitary adenoma

From: Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

Parameter

Groups

Pituitary adenoma

(n = 71)

Non-Functional pituitary adenoma

(n = 30)

Functional pituitary adenoma

(n = 41)

Acromegaly

(n = 20)

Cushing

(n = 13)

Prolactinoma

(n = 8)

Age (Years)

20–40

34(47.88%)

13(43.33%)

21(51.21%)

10(50%)

7(53.84%)

4(50%)

40–60

22(30.98%)

9(30%)

13(31.70%)

6(30%)

5(38.46%)

2(25%)

60≤

15(21.12%)

8(26.66%)

7(17.07%)

4(20%)

1(7.69%)

2(25%)

Gender

Female

34(47.88%)

12(40%)

22(53.65%)

11(55%)

8(61.53%)

3(37.5%)

Male

37(52.11%)

18(60%)

19(46.34%)

9(45%)

5(38.46%)

5(62.5%)

Tumor invasiveness

Invasive

33(46.47%)

13(43.33%)

20(48.78%)

10(50%)

4(30.76%)

6(75%)

Non- Invasive

38(53.52%)

17(56.66%)

21(51.21%)

10(50%)

9(69.23%)

2(25%)

Tumor size

Micro-Adenoma

16(22.53%)

0

16(39.02%)

8(40%)

8(61.53%)

0

Macro-Adenoma

55(77.46%)

30(100%)

25(60.97%)

12(60%)

5(38.46%)

8(100%)